[go: up one dir, main page]

WO2006129160A3 - Stable aqueous oral solution of risperidone - Google Patents

Stable aqueous oral solution of risperidone Download PDF

Info

Publication number
WO2006129160A3
WO2006129160A3 PCT/IB2006/001391 IB2006001391W WO2006129160A3 WO 2006129160 A3 WO2006129160 A3 WO 2006129160A3 IB 2006001391 W IB2006001391 W IB 2006001391W WO 2006129160 A3 WO2006129160 A3 WO 2006129160A3
Authority
WO
WIPO (PCT)
Prior art keywords
risperidone
stable aqueous
oral solution
aqueous oral
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2006/001391
Other languages
French (fr)
Other versions
WO2006129160A2 (en
Inventor
Subhashini Radhakrishnan
Ashish Gogia
Sivakumaran Meenakshisunderam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aurobindo Pharma Ltd
Original Assignee
Aurobindo Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Ltd filed Critical Aurobindo Pharma Ltd
Publication of WO2006129160A2 publication Critical patent/WO2006129160A2/en
Publication of WO2006129160A3 publication Critical patent/WO2006129160A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to stable aqueous solutions of antipsychotic drug. More particularly, the present invention relates to stable aqueous solutions of risperidone, wherein the composition is free of buffering agents. The present invention also relates to preparation of stable aqueous solutions of risperidone, wherein the composition is free of buffering agents.
PCT/IB2006/001391 2005-06-01 2006-05-29 Stable aqueous oral solution of risperidone Ceased WO2006129160A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN671CH2005 2005-06-01
IN671/CHE/2005 2005-06-01

Publications (2)

Publication Number Publication Date
WO2006129160A2 WO2006129160A2 (en) 2006-12-07
WO2006129160A3 true WO2006129160A3 (en) 2007-07-12

Family

ID=37482024

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/001391 Ceased WO2006129160A2 (en) 2005-06-01 2006-05-29 Stable aqueous oral solution of risperidone

Country Status (1)

Country Link
WO (1) WO2006129160A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4941977B2 (en) * 2007-04-11 2012-05-30 大蔵製薬株式会社 Oral jelly-like pharmaceutical composition of benzisoxazole derivative
HRP20170089T1 (en) * 2009-01-20 2017-03-24 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical
TWI671287B (en) 2016-06-13 2019-09-11 心悅生醫股份有限公司 Co-crystals of sodium benzoate and uses thereof
CA3027300C (en) 2016-06-13 2023-08-08 Syneurx International (Taiwan) Corp. Co-crystals of lithium benzoate and uses thereof
US10336679B2 (en) 2016-10-24 2019-07-02 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
US11369579B2 (en) 2016-10-24 2022-06-28 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
US10098861B1 (en) 2017-10-24 2018-10-16 Syneurx International (Taiwan) Corp. Pharmaceutical composition comprising sodium benzoate compound and clozapine, and uses thereof
CN114994198B (en) * 2022-05-20 2023-02-28 上海市精神卫生中心（上海市心理咨询培训中心） Method for simultaneously and quantitatively detecting 78 neuropsychiatric drugs by liquid chromatography-mass spectrometry

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
WO1996001652A1 (en) * 1994-07-11 1996-01-25 Janssen Pharmaceutica N.V. Aqueous risperidone formulations
WO2004017975A1 (en) * 2002-08-23 2004-03-04 Ranbaxy Laboratories Limited Stable aqueous solutions of risperidone and methods for their preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
WO1996001652A1 (en) * 1994-07-11 1996-01-25 Janssen Pharmaceutica N.V. Aqueous risperidone formulations
WO2004017975A1 (en) * 2002-08-23 2004-03-04 Ranbaxy Laboratories Limited Stable aqueous solutions of risperidone and methods for their preparation

Also Published As

Publication number Publication date
WO2006129160A2 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
MX2010004576A (en) Novel pyrimidine derivatives.
WO2009074950A3 (en) Thiophene derivatives as agonists of s1p1/edg1
NO20076648L (en) Novel thiophene derivatives
CA2661102C (en) Thiophene derivatives as s1p1/edg1 receptor agonists
MY154909A (en) Novel thiophene derivatives
WO2006100635A3 (en) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
TW200700406A (en) Novel thiophene derivatives
TW200716591A (en) Novel thiophene derivatives
WO2007086001A3 (en) Novel pyridine derivatives
WO2007061360A3 (en) Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides
NO20082793L (en) New thiophene derivatives
WO2009145456A3 (en) Heterocyclic derivatives
MX2010005827A (en) Aminopyrazole derivatives.
TW200942524A (en) Novel aminomethyl benzene derivatives
WO2011006935A3 (en) Tetrazole derivatives
WO2006129160A3 (en) Stable aqueous oral solution of risperidone
WO2007070517A3 (en) Fexofenadine suspension formulation
IL194094A0 (en) Stable pharmacuetical compositions of 2-aza-bicyclol[3.3.0]-octane-3-carboxylic acid derivatives
WO2007138462A3 (en) Aqueous oral formulations of risperidone
WO2006056695A8 (en) Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof
WO2007079915A3 (en) Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect
WO2007121883A3 (en) 1,4:3,6-dianhydromannitol derivatives and use thereof
WO2007000655A3 (en) Novel pyrazolopyrimidinone derivatives
WO2006055663A3 (en) The use of novel antibacterial compounds
TW200531693A (en) Prolonged-release diuretic compositions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06744780

Country of ref document: EP

Kind code of ref document: A2